Clinical trials in stem cell transplantation: guidelines for scientific and ethical review

Author:

Lo Bernard1,Kriegstein Arnold2,Grady Deborah3

Affiliation:

1. Program in Medical Ethics and Department of Medicine, University of California, San Francisco, 521 Parnassus Avenue, Room C126, San Francisco, CA 94143-0903, USA,

2. Program in Developmental and Stem Cell Biology and Department of Neurology, University of California, San Francisco, 521 Parnassus Avenue, Room C126, San Francisco, CA 94143-0903, USA

3. Department of Medicine, The San Francisco VA Medical Center, University of California, San Francisco, 521 Parnassus Avenue, Room C126, San Francisco, CA 94143-0903, USA

Abstract

Background Transplantation of cells derived through the manipulation of pluripotent stem cells may involve great uncertainty and the possibility of serious risks. Purpose To develop guidelines for the ethical conduct of clinical trials using such stem cells. Methods Review of literature on clinical trials ethics and clinical applications of stem cells; critical deliberation on potential guidelines. Results Such transplantation should be allowed in clinical practice only after clinical trials demonstrate efficacy and safety. These clinical trials should follow ethical principles that guide all clinical research. Additional requirements to strengthen trial design, coordinate scientific and ethics review, verify that participants understand key features of the trial, and ensure publication of findings are also warranted because of the highly innovative nature of the intervention, limited experience in humans, and the high hopes of patients who have no alternative effective treatments. Limitations These recommendations will need to be modified in light of actual experience with stem cell clinical trials. Conclusions These recommendations will help guarantee that the efficacy and safety of innovative stem cell interventions will be rigorously established, while also protecting study participants. Clinical Trials 2008; 5: 517—522. http:// ctj.sagepub.com

Publisher

SAGE Publications

Subject

Pharmacology,General Medicine

Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3